[RDHL] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -70.41%
YoY- -27.94%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 2,001 100 0 1 1 4 3 195.29%
PBT -10,413 -8,349 -6,560 -5,328 -3,440 -3,352 0 -
Tax -787 1,013 -80 0 45 1,237 161 -
NP -10,413 -8,349 -6,560 -5,328 -3,440 -3,352 -2,620 25.83%
Tax Rate - - - - - - - -
Total Cost 12,414 8,449 6,560 5,329 3,441 3,356 2,623 29.54%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -520.39 -8,349.00 0.00 -532,800.00 -344,000.00 -83,800.00 -87,333.33 -57.38%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -20.70 -24.00 -21.04 -24.25 -21.47 -25.30 -20.01 0.56%
EPS Diluted -20.00 -24.00 -20.64 -24.25 -21.47 -25.30 -20.01 -0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.